Carrier state of pP-7 in patients with neoplasias of different origins
| . | Value, n/N . |
|---|---|
| Follicular lymphoma | 1/50 |
| MCL | 1/29 |
| DLBCL | 1/100 |
| Hodgkin lymphoma | 1/58 |
| CLL | 0/50 |
| ALL/AML | 1/33 |
| Breast cancer | 1/50 |
| Lung cancer | 0/50 |
| Colon cancer | 0/50 |
| Prostate cancer | 1/50 |
| Melanoma | 1/66 |
| Total | 8/586 |
| . | Value, n/N . |
|---|---|
| Follicular lymphoma | 1/50 |
| MCL | 1/29 |
| DLBCL | 1/100 |
| Hodgkin lymphoma | 1/58 |
| CLL | 0/50 |
| ALL/AML | 1/33 |
| Breast cancer | 1/50 |
| Lung cancer | 0/50 |
| Colon cancer | 0/50 |
| Prostate cancer | 1/50 |
| Melanoma | 1/66 |
| Total | 8/586 |
MCL indicates mantle cell lymphoma; DLBCL, diffuse large B-cell lymphoma; CLL, chronic lymphocytic leukemia; ALL, acute lymphoblastic leukemia; and AML, acute myelocytic leukemia.